N2K, and rrr2003; I give a great deal of credit to NH for his persistence in pursuit of making Elite a viable pharmaceutical. If it were anyone else they may have take n a different approach sticking solely with the ADF. As you have pointed out a couple of times N2K, his diversification of the drug portfolio is really what may end up saving Elite's bacon.
Patience is the real key for serious investors right now. When it all plays out we will see who was right and who was dead wrong.
Now is the time to add to ones holdings. Just sit back and wait it out.